Tonix Pharmaceuticals (TNXP) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-3.98
-3.58
-3.17
-2.77

Details

Expected EPS
-3.19
Actual EPS
-3.98
Surprise EPS
-0.79
Surprise Percent
+24.76%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -3.98 per share for Q1 2026.

0 Comments

Share your thoughts